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Effects of a Mindfulness-Based Weight Loss Intervention in
Adults with Obesity: A Randomized Clinical Trial
Jennifer Daubenmier1,2,3, Patricia J. Moran1, Jean Kristeller4, Michael Acree1, Peter Bacchetti5, Margaret E. Kemeny6,
Mary Dallman2,7, Robert H. Lustig2,8, Carl Grunfeld2,3,9, Douglas F. Nixon10,11, Jeffrey M. Milush3, Veronica Goldman1,
Barbara Laraia2,12, Kevin D. Laugero13, Leslie Woodhouse13, Elissa S. Epel2,7,*, and Frederick M. Hecht1,2,3,*
Objective: To determine whether adding mindfulness-based eating and stress management practices to
a diet-exercise program improves weight loss and metabolic syndrome components.
Methods: In this study 194 adults with obesity were randomized to a 5.5-month program with or without
mindfulness training and identical diet-exercise guidelines. Intention-to-treat analyses with multiple impu-
tation were used for missing data. The primary outcome was 18-month weight change.
Results: Estimated effects comparing the mindfulness to control arm favored the mindfulness arm in (a)
weight loss at 12 months, 21.9 kg (95% CI: 24.5, 0.8; P 5 0.17), and 18 months, 21.7 kg (95% CI:
24.7, 1.2; P 5 0.24), though not statistically significant; (b) changes in fasting glucose at 12 months,
23.1 mg/dl (95% CI: 26.3, 0.1; P 5 0.06), and 18 months, 24.1 mg/dl (95% CI: 27.3, 20.9; P 5 0.01);
and (c) changes in triglyceride/HDL ratio at 12 months, 20.57 (95% CI: 20.95, 20.18; P 5 0.004), and 18
months, 20.36 (95% CI: 20.74, 0.03; P 5 0.07). Estimates for other metabolic risk factors were not stat-
istically significant, including waist circumference, blood pressure, and C-reactive protein.
Conclusions: Mindfulness enhancements to a diet-exercise program did not show substantial weight
loss benefit but may promote long-term improvement in some aspects of metabolic health in obesity that
requires further study.
Obesity (2016) 00, 00–00. doi:10.1002/oby.21396
Introduction
Obesity and metabolic syndrome are among the most pressing public
health issues in the United States today (1). Key features of meta-
bolic syndrome include central obesity, impaired glucose metabo-
lism, lipid abnormalities, and hypertension (2) with resultant
increased risk of type 2 diabetes, cardiovascular disease, stroke, and
mortality (3,4). Age-adjusted prevalence of metabolic syndrome in
the United States was 34% from 1999 to 2006 (5).
Modest weight loss usually improves metabolic risk factors (6). How-
ever, weight loss maintenance is challenging. A meta-analysis of over 80
weight loss programs found weight loss of 5–9% after 6 months, yet half
the weight was regained after 4 years (7). One factor that disrupts weight
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Original Article
CLINICAL TRIALS AND INVESTIGATIONS
Obesity
loss efforts and contributes to metabolic dysfunction is psychological
stress. Over one in four Americans report overeating or eating unhealthy
foods to manage stress (8). Animal, epidemiological, and mechanistic
studies have linked stress to dysregulated eating, weight gain, impaired
glucose metabolism, abdominal adiposity, and lipid abnormalities (9-11).
Individuals also eat mindlessly in response to external cues and the
rewarding value of food, overriding homeostatic hunger and satiety sig-
nals, which can be exacerbated by stress (12,13). However, stress man-
agement and techniques that promote increased responsiveness to
homeostatic signals regulating food intake are not core components of
most weight loss programs.
Meditation interventions, including mindfulness-based approaches, can
be effective in reducing psychological stress (14). Mindfulness medita-
tion, which cultivates awareness of present-moment experience with a
nonjudging attitude, is theorized to promote adaptive self-regulation,
which is thought to be key to maintaining long-term eating habits, partic-
ularly in the face of stress (15). Evidence suggests that mindfulness-
based interventions improve eating behaviors, weight management, and
metabolic health (16-22), but rigorous long-term randomized-controlled
trials are limited (14). To address this gap, we performed a randomized-
controlled trial to estimate the effects of adding mindfulness components
to a diet-exercise program on weight loss and cardiometabolic risk fac-
tors in adults with obesity over a 5.5-month intervention period with a
subsequent 1 year of follow-up. We hypothesized that the mindfulness
intervention relative to the active control would show greater improve-
ments in maintenance of weight loss and cardiometabolic risk factors up
to 1 year after intervention termination.
Methods
Study design
We randomized adults with obesity in a 1:1 ratio to a 5.5-month diet-
exercise intervention with or without mindfulness components. Partic-
ipants were assessed at baseline and 3, 6, 12, and 18 months from
intervention initiation. The primary outcome was 18-month weight
change. The University of California, San Francisco (UCSF) Commit-
tee on Human Research approved study procedures and participants
provided informed consent. The intervention was provided free of
charge at UCSF; participants were compensated for assessment visits.
Participants
Eligibility criteria included body mass index (BMI) between 30 and
45.9, abdominal obesity (waist circumference> 102 cm for
men;> 88 cm for women), and age 18 or older. Exclusion criteria
included diabetes mellitus, fasting glucose 126 mg/dl, or hemoglo-
bin A1c (HbA1c) between 6.0% and 6.5% with an abnormal oral
glucose tolerance test and current weight loss diet or taking medica-
tions that may affect weight. See Supporting Information, Table S1
for further eligibility criteria.
Participant flow
We recruited participants for a weight loss study comparing two
programs involving diet, exercise, and stress management from the
community using fliers, newspaper advertisements, online postings,
and referrals at UCSF clinics. Participants were enrolled in six
rounds from July 2009 to February 2012. Assessments were com-
pleted in October 2013.
A computer-generated random allocation sequence using random
block sizes of four to eight was programmed by a database manager
not involved in enrollment. No other staff had access to the random-
ization sequence. The project director (PM) accessed the allocation
sequence using a programmed database that could not be altered
once randomized condition was revealed.
Intervention groups
Diet and exercise guidelines. Both interventions included iden-
tical diet-exercise guidelines presented in 45-min segments per ses-
sion. The dietary component recommended healthy food choices
that emphasized modest calorie reduction (typically 500 kcal/day),
including decreasing calorie-dense nutrient-poor foods, decreasing
simple carbohydrates and substituting whole grains, and increasing
consumption of fresh fruits and vegetables, healthy oils, and pro-
teins. The exercise component emphasized increasing daily activity
and moderate-intensity exercise, primarily through walking, and
strength training (see Supporting Information, Methods).
Mindfulness intervention. The mindfulness intervention added
mindfulness training for stress management, eating, and exercise.
Meditation practices, modeled on the mindfulness-based stress
reduction program, included sitting meditation, loving kindness, and
yoga postures (23). Mindful eating practices, modeled on the Mind-
fulness-Based Eating Awareness Training program, were designed to
enhance awareness and self-regulation of physical hunger, stomach
fullness, taste satisfaction, food cravings, emotions, and other eating
triggers in the context of reduced caloric intake (16,17,24). Mindful
walking included awareness of sensory experience, posture, and
alignment (25). Home practice guidelines included meditation prac-
tice for up to 30 min a day/6 days a week, eating meals mindfully,
and use of mini-meditations.
Active control intervention. To control for attention, social sup-
port, expectations of benefit, food provided during the mindful eat-
ing exercises, and home practice time in the mindfulness interven-
tion, the control intervention included additional nutrition and
physical activity information, strength training with exercise bands,
discussion of societal issues concerning weight loss, snacks, and
home activities. We controlled for a mindfulness approach to stress
management by including progressive muscle relaxation and
cognitive-behavioral training in the control group, although at a
lower dose than in the mindfulness intervention (see Supporting
Information, Methods and Figure S1 for more details of both inter-
vention groups).
Both interventions included 16 sessions lasting 2 to 2.5 h (12
weekly, 3 biweekly, and 1 monthly) and one all-day session (6.5
and 5 h in the mindfulness and control interventions, respectively)
over 5.5 months. Additional diet, exercise, and stress management
content in the control intervention was shortened by 30 min in ses-
sions 9–16 to increase participant acceptability with the primary
goal to match groups on expectations of benefit. Based on pilot test-
ing, we felt that longer sessions might decrease perceived benefit.
The mindfulness intervention was led by one of three mindfulness
meditation instructors and co-led by the same registered dietitian
(except for one cohort). The control intervention was led by one of
three registered dietitians masked to study hypotheses. Participants
had three individual consultations with instructors.
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Measurements
Participants were assessed between 8 and 10 A.M. (with occasional
exceptions) under fasting conditions. Weight, height, blood pressure,
and waist circumference were measured (see Supporting Informa-
tion, Methods). Staff was not masked to group assignment; as feasi-
ble, staff either conducted assessments, or coordinated intervention
sessions to minimize unmasking. A blood specimen was obtained
for glucose, lipids, HbA1c, insulin, and C-reactive protein. Staff per-
forming assays was masked to group assignment.
Statistical analysis
We performed intention-to-treat analyses on change in weight and
cardiometabolic outcomes, using independent t-tests to compare
means between arms using observed data. We compared these anal-
yses of observed data to the primary analyses, mixed models that
used multiple imputation to replace missing data, based on guide-
lines for reporting and interpreting results of multiple imputation
analyses (26). Missing data were handled using SAS version 9.4
(SAS Institute Inc) procedures PROC MI and MIANALYZE. Impu-
tation models for each outcome variable included values at other
time points, attendance (counting the all-day session as two) and its
interaction with arm, and an arm 3 round interaction term
(ROUNDARM) to adjust for clustering effects. One thousand data-
sets were imputed for each outcome using the fully conditional spec-
ification method with predictive mean matching. We compared these
results with nonimputed mixed models adjusting for ROUNDARM.
For both types of models, arm, time, and their interaction were
included as fixed effects, and person and ROUNDARM as random
effects. Nonimputed models produced estimates similar to those of
imputed models (Supporting Information, Table S2).
Power calculation. In our pilot study (16), we found a 2.0 kg
between-group difference in weight change among participants with
obesity post-intervention. We expected a smaller difference in the
present trial due to an active comparison and a longer follow-up
period. We planned for 200 participants based on pilot data and
available resources. We estimated 85% power to find P< 0.05 if the
true difference was 1.1 kg.
Secondary analyses of mindfulness instructors. Anonymous
qualitative feedback from participants and qualitative supervisor
assessments of session recordings during the trial raised some con-
cerns that mindfulness teaching by one instructor (C) might be less
effective than that of other mindfulness instructors (A and B). As a
post-hoc analysis, we, therefore, categorized rounds by mindfulness
instructor (A/B vs. C) and examined arm 3 categorized round inter-
actions on outcomes, and also compared differences between mind-
fulness groups led by instructors A/B to all control groups and con-
temporaneous control groups We further compared instructor C to
instructor A/B groups on instructor helpfulness ratings on a 1- to 4-
point scale from anonymous questionnaires administered throughout
the intervention (see Supporting Information, Methods).
Results
We randomized 194 participants to two arms (Figure 1) with similar
baseline characteristics (see Table 1). Session attendance was similar
for the mindfulness and control arms (74.7% vs. 71.2%, respectively;
P 5 0.55), as was 18-month retention (81% vs. 71%, respectively;
P 5 0.13). Mindfulness participants, on average, reported meditating
2.1 (SD 5 1.2) hours/week (70% of recommendations) and eating
57% (SD 5 29) of meals mindfully (see Supporting Information,
Table S3 for additional adherence results). Participants with missing
data at 18 months had lower attendance and baseline HbA1c levels;
were younger, less educated, and more likely to be non-White (Sup-
porting Information, Table S4). Mindfulness compared to control par-
ticipants with missing 18-month data reported greater decreases in
expectations of benefit from pre- to post-randomization, attended
fewer sessions, tended to have better baseline lipid profiles, and,
among those with post-randomization data, showed nonsignificant pat-
terns of less improvement in metabolic risk factors (Supporting Infor-
mation, Tables S5 and S6). No serious adverse events were observed
in either intervention arm.
Weight loss
Between-group estimates of weight loss generally became larger
over time with estimates favoring the mindfulness arm (see Table 2;
Supporting Information, Table S7 for body mass index). At 12
months, group differences became most pronounced with a differ-
ence of 21.9 kg (95% CI: 24.5, 0.8; P 5 0.17) in imputation analy-
ses; observed data analyses estimated a slightly larger difference,
22.1 kg (95% CI: 24.3, 0.05; P 5 0.06). At 18 months, the group
difference was largely maintained in imputation analyses, 21.7 kg
(95% CI: 24.7, 1.2 kg; P 5 0.24): the mindfulness arm lost 4.2 kg
(95% CI: 26.2, 22.2 kg), whereas the control arm lost 2.4 kg (95%
CI: 24.5, 20.3 kg). Observed data analyses yielded similar results.
Cardiometabolic outcomes
At 12 months, group differences in fasting glucose levels favored
the mindfulness arm, 23.1 mg/dl (95% CI: 26.3, 0.1; P 5 0.06),
and, at 18 months, differences were statistically significant,
24.1 mg/dl (95% CI: 27.3, 20.9; P 5 0.01), in imputation analyses.
At 18 months, glucose levels did not change substantially in the
mindfulness arm, 20.31 mg/dl (95% CI: 22.5, 1.9), but increased
in the control arm, 3.8 mg/dl (95% CI: 1.5, 6.1). Observed data
analyses were consistent.
At 12 months, group differences in the triglyceride/HDL ratio favor-
ing the mindfulness arm were statistically significant, 20.57 (95%
CI: 20.95, 20.18; P 5 0.004), in imputation analyses. The triglycer-
ide/HDL ratio decreased in the mindfulness arm, 20.29 (95% CI:
20.54, 20.04), and tended to increase in the control arm, 0.28
(95% CI: 20.01, 0.57). At 18 months, the group difference was
attenuated, 20.36 (P 5 0.07), although the observed data analysis
remained statistically significant (20.41, P 5 0.04).
Similarly, at 12 months, group differences in triglycerides favored
the mindfulness arm, 217.6 mg/dl (95% CI: 233.6, 21.7;
P 5 0.03), in imputation analyses. Triglycerides decreased in the
mindfulness arm, 214.3 mg/dl (95% CI: 224.8, 23.8), but did not
change substantially in the control arm, 3.4 mg/dl (95% CI: 28.6,
15.3). At 18 months, group differences were attenuated in both
imputation (29.7 mg/dl, P 5 0.23) and observed data analyses
(28.9 mg/dl, P 5 0.24; Figure 2).
At 18 months, group differences in other metabolic and inflamma-
tory outcomes did not approach statistical significance in imputation
analyses (see Table 2 and Supporting Information, Table S7 for total
cholesterol). However, observed data analyses indicated that the
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Figure 1 Participant flowchart. There were 1485 individuals who contacted us in response to advertisements for this trial, 216 individuals who were fully eligi-
ble, and 194 individuals who met eligibility criteria and elected to enroll in the trial.
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mindfulness arm tended to show improvements over the control arm
in HOMA (P 5 0.07), HDL (P 5 0.05), and C-reactive protein
(P 5 0.09).
Secondary analyses of mindfulness instructors
Mindfulness instructor C was rated as less helpful during the inter-
vention (mean 5 3.50; SD 5 0.7) than instructors A/B (mean 5 3.68;
SD 5 0.5; P 5 0.045). Significant interactions (P< 0.05) were found
between arm and rounds categorized by mindfulness instructor (A/B
vs. C) on weight, BMI, fasting glucose, HOMA, and HbA1c, with a
marginally significant effect for waist circumference (P 5 0.08).
Follow-up analyses indicated that at 18 months, instructor C partici-
pants lost less weight, 22.0 kg (95% CI: 24.7, 0.7), compared to
instructor A/B participants, 26.3 kg (95% CI: 29.1, 23.6;
P 5 0.02; Table 3 and Figure 3). This difference persisted after
adjusting for participant age, gender, education, and ethnicity (Sup-
porting Information, Table S8). A comparison of mindfulness
instructors A/B to the control arm indicated a difference of 3.9 kg
favoring the mindfulness group (95% CI: 27.4, 20.4 kg; P 5 0.03;
Table 3). Mindfulness groups led by instructors A/B also had greater
18-month reductions in BMI (Supporting Information, Table S9) and
waist circumference (Table 3) compared to Instructor C groups
(P 5 0.02 and P 5 0.05, respectively) and the control arm (P 5 0.02
and 0.03, respectively). Similar results were found if we restricted
control groups to those enrolled in the same rounds as those led by
instructors A/B, indicating that differences favoring mindfulness
instructor A/B groups were unlikely to be due to temporal patterns
of participant enrollment (Supporting Information, Table S10). Spe-
cifically, for weight, mindfulness instructor A/B groups lost 6.3 kg
at 18 months and the control groups enrolled in the same round lost
0.9 kg, a difference of 5.4 kg (95% CI: 29.0, 21.8; P 5 0.004).
Discussion
We examined the impact of adding mindfulness training to a diet-
exercise weight loss program in adults with obesity. Participants
receiving mindfulness training had a nonstatistically significant
1.7 kg greater weight loss at 18 months on average compared to
control participants. Because this additional weight loss is not likely
to confer clinical benefit, these results do not support adding mind-
fulness components to diet-exercise programs to enhance weight
loss. Nevertheless, these results should not be viewed as conclusive
evidence against the inclusion of mindfulness components in weight
loss programs. The 95% confidence interval included weight loss
advantages that may be clinically important.
Findings from secondary outcomes provide modest support for
potential benefits of adding mindfulness components to diet-exercise
programs for obesity. Overall, we assessed 11 outcomes related to
weight, metabolic syndrome, or cardiovascular risk. Ten of these
outcomes favored the mindfulness group at 12 months, and 9 at 18
months, some with statistically significant differences. We found a
statistically significant 4.1 mg/dl difference in fasting glucose favor-
ing the mindfulness arm at 18 months. The difference was primarily
due to an increase of 2.5 mg/dl/year in the control arm and mainte-
nance of glucose levels in the mindfulness arm. The increase in glu-
cose levels among control participants is similar to increases
observed in persons at risk of type 2 diabetes in other studies, such
as the control group in the Diabetes Prevention Program (about
2 mg/dl/year), suggesting that an expected increase in fasting glu-
cose over time was prevented among mindfulness participants (27).
In population studies, each increase of 1 mg/dl in fasting glucose in
the range typical of participants in this study corresponds to a 1–2%






Age, mean (SD) (years) 47.2 (13.0) 47.8 (12.4)
Sex, No. (%), female 79 (79) 81 (86)
Ethnic Origin, No. (%)
European 65 (65.0) 50 (53.0)
African 13 (13.0) 12 (12.8)
Asian/Pacific Islander 8 (8.0) 11 (11.7)
Latina/Latino 7 (7.0) 16 (17.0)
Native American 0 (0.0) 2 (2.1)
Other 7 (7.0) 3 (3.2)
Education, No. (%), bachelor’s degreea 69 (69.7) 56 (59.6)
Weight, mean (SD) (kg) 97.7 (14.1) 96.7 (14.8)
Body mass index, mean (SD)b 35.4 (3.5) 35.6 (3.8)
Waist circumference, mean (SD) (cm) 112.9 (9.7) 112.7 (10.6)
Glucose, mean (SD) (mg/dl) 86.6 (8.7) 85.5 (7.7)
HOMA, mean (SD)c 2.2 (1.4) 2.4 (1.8)
HbA1c, mean (SD) (%) 5.6 (0.4) 5.6 (0.3)
Lipids, mean (SD) (mg/dl)
Total cholesterol 198.5 (37.5) 196.4 (34.8)
LDL cholesterol 117.2 (31.3) 117.3 (31.0)
HDL cholesterol 55.7 (15.0) 54.9 (13.0)
Triglycerides 128.0 (68.1) 121.0 (45.1)
Triglyceride/HDL ratio 2.6 (1.8) 2.4 (1.3)
Blood pressure, mean (SD) (mm Hg)
Systolic 122.4 (16.6) 124.1 (16.8)
Diastolic 70.7 (10.7) 70.5 (9.5)
C-reactive protein, mean (SD) (mg/l) 5.4 (5.5) 4.7 (4.2)
Medications, No. (%)
Lipid lowering 11 (11.0) 9 (9.6)
Blood pressure 16 (16.0) 21 (22.3)
Antidepressant 17 (17.0) 16 (17.0)
Metabolic syndrome, No. (%)d 28 (28.0) 27 (28.7)
No significant differences were observed between groups at baseline using inde-
pendent samples t-tests (P< 0.05).
aOne participant in the mindfulness arm was missing education data.
bCalculated as weight (kg) divided by height (m2).
cHOMA is an abbreviation for homeostatic homeostasis model assessment of insu-
lin resistance and is defined as (glucose 3 insulin/(40 3 33.25)).
dThe criteria for metabolic syndrome were based on the guidelines developed by
the National Cholesterol Program’s Adult Treatment Panel III report. Metabolic syn-
drome was defined as the presence of three or more risk factors: increased waist
circumference (88 cm for women; 102 cm for men); elevated triglycerides
(150 mg/dl) or medication use; low HDL cholesterol (<50 mg/dl in women;
<40 mg/dl in men) or medication use; hypertension (130/85 mm Hg) or medi-
cation use; and impaired fasting glucose (110 mg/dl).
HOMA, homeostatic model assessment (insulin resistance); HbA1c, hemoglobin A1c
(glycosylated hemoglobin); LDL, low-density lipoprotein; HDL, high-density
lipoprotein.
SI conversion factors: To convert HDL, LDL, and total cholesterol values to milli-
moles per liter, multiply by 0.0259; to convert triglycerides to millimoles per liter,
multiply by 0.0113; to convert glucose values to millimoles per liter, multiply by
0.0555.
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increase in the likelihood of developing type 2 diabetes, suggesting
that our observed difference may be clinically significant (28,29).
Triglycerides and the triglyceride/HDL ratio showed moderate evi-
dence of long-term improvement, as these decreased in the mindful-
ness compared to the control arm at 12 months, although differences
were not statistically significant at 18 months. Elevated triglycerides
and low HDL are both features of metabolic syndrome, and the ratio
predicts cardiovascular mortality (30).
Improvements in fasting glucose and lipids may be related to greater
improvements in mindfulness or stress management, greater weight
loss in the mindfulness arm, or differences in food choices. In a sep-
arate analysis (31), participants in the mindfulness arm maintained
reductions in sweet food intake from 6 to 12 months in comparison
to participants in the control arm. Greater meditation and/or mindful
eating practice during the intervention was related to greater weight
loss, lower triglyceride/HDL ratio, and a trend for lower fasting glu-
cose at 6 months, though not at 18 months (see Supporting Informa-
tion, Table S11). Future analyses will examine to what extent mind-
fulness, stress reduction, or behavioral changes account for benefits
observed in the mindfulness condition. We did not, however, find
significant differences in insulin sensitivity (HOMA), a key second-
ary outcome, or HbA1c levels. This may be due, in part, to the fact
that we excluded participants with HbA1c levels above 6.5%, which
meant there was limited room for improvement among enrolled
participants.
Although we believe that the total number of metabolic outcomes
favoring the mindfulness arm suggests possible benefits of mindful-
ness components, we also note important cautions. Only the differ-
ences in fasting glucose were consistently statistically significant.
We did not apply an adjustment for multiple-comparison testing
because standard adjustments do not account for the expected direc-
tion of outcomes and coherence of the ensemble of findings. Yet,
the multiplicity of outcomes assessed increases the risk that some
statistically significant findings are due to chance. Future replication
is needed to place greater confidence in these findings.
Most behavioral interventions show maximal weight loss at 6
months and gradual regain thereafter (7). This pattern was
observed in our control group. In contrast, mindfulness participants
maintained weight loss, regaining an average of only 0.3 kg from 6
to 18 months. The mindfulness intervention resulted in a mean of
4.2–5.0 kg (4.3–5.1%) 18-month weight loss, depending on ana-
lytic method. According to recent obesity guidelines, sustained
weight loss of as little as 3–5% is likely to result in clinically
meaningful reductions in levels of fasting glucose and triglycer-
ides, as found in our study, and in the risk of developing type 2
diabetes (32).
We note that in interpreting these results our 5.5-month intervention
dose was modest compared to many weight loss trials that provide con-
tinuous contact and current obesity intervention guidelines (32-34).
Figure 2 Changes in weight and metabolic risk factors over time. Each panel shows changes from trial initiation in metabolic risk factors,
with the control group in gray lines and the mindfulness group in black lines. Standard error bars are shown. Panel A shows changes in
weight, panel B shows changes in fasting glucose, and panel C shows changes in triglyceride/HDL ratio. See Table 2 for statistical tests
at different time points. m 5 months; TG 5 triglycerides.
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3m 23.7 (1.2) 23.2 (1.2) 0.5 (22.9, 3.9) 0.76 20.6 (23.6, 2.4) 0.68
6m 24.8 (1.2) 24.1 (1.2) 0.7 (22.7, 4.2) 0.67 21.6 (24.7, 1.5) 0.31
12m 25.2 (1.3) 23.6 (1.3) 1.6 (21.9, 5.1) 0.37 22.7 (26.0, 0.7) 0.11
18m 26.3 (1.4) 22.0 (1.3) 4.3 (0.8, 7.9) 0.02 23.9 (27.4, 20.4) 0.03
Waist circumference (cm)
3m 23.4 (1.4) 21.9 (1.4) 1.6 (22.4, 5.6) 0.44 21.2 (23.9, 1.5) 0.37
6m 25.0 (1.5) 23.5 (1.5) 1.5 (22.6, 5.5) 0.48 21.2 (24.0, 1.6) 0.41
12m 25.6 (1.5) 22.2 (1.5) 3.4 (20.7, 7.5) 0.11 23.6 (26.6, 20.6) 0.02
18m 26.3 (1.5) 22.2 (1.6) 4.1 (20.1, 8.3) 0.05 23.5 (26.7, 20.3) 0.03
Glucose (mg/dl)
3m 21.9 (1.2) 1.6 (1.2) 3.5 (0.3, 6.8) 0.03 22.3 (26.3, 1.8) 0.27
6m 0.8 (1.2) 20.8 (1.2) 21.6 (24.9, 1.8) 0.35 20.2 (24.3, 4.0) 0.94
12m 20.3 (1.3) 0.9 (1.3) 1.2 (22.2, 4.6) 0.49 23.7 (27.9, 0.6) 0.09
18m 20.9 (1.3) 0.3 (1.2) 1.3 (22.1, 4.7) 0.45 24.8 (29.0, 20.5) 0.03
HOMA
3m 20.05 (0.33) 0.09 (0.32) 0.14 (20.75, 1.04) 0.75 20.02 (20.91, 0.86) 0.96
6m 20.05 (0.33) 20.19 (0.32) 20.14 (21.03, 0.76) 0.76 20.02 (20.91, 0.87) 0.97
12m 20.27 (0.35) 0.01 (0.33) 0.28 (20.65, 1.20) 0.55 20.72 (21.68, 0.24) 0.14
18m 20.19 (0.32) 0.11 (0.32) 0.30 (20.59, 1.19) 0.51 20.60 (21.52, 0.32) 0.20
HbA1c (%)
3m 20.07 (0.08) 0.07 (0.07) 0.14 (20.07, 0.35) 0.19 20.06 (20.22, 0.10) 0.43
6m 20.11 (0.07) 0.02 (0.07) 0.13 (20.08, 0.34) 0.23 20.11 (20.27, 0.05) 0.19
12m 20.09 (0.08) 20.04 (0.08) 0.05 (20.16, 0.26) 0.62 20.07 (20.23, 0.10) 0.43
18m 20.11 (0.08) 0.01 (0.08) 0.12 (20.09, 0.33) 0.25 20.12 (20.28, 0.04) 0.15
LDL (mg/dl)
3m 22.8 (3.4) 25.3 (3.2) 22.5 (211.6, 6.6) 0.59 2.3 (25.9, 10.6) 0.58
6m 2.7 (3.4) 23.0 (3.4) 25.7 (215.0, 3.5) 0.22 6.4 (22.2, 15.0) 0.14
12m 0.7 (3.4) 20.4 (3.4) 21.1 (210.4, 8.2) 0.81 5.7 (23.0, 14.3) 0.20
18m 21.6 (3.5) 21.1 (3.5) 0.4 (29.0, 9.8) 0.93 2.1 (26.9, 11.1) 0.64
HDL (mg/dl)
3m 21.9 (1.5) 21.4 (1.5) 0.5 (23.8, 4.8) 0.82 1.3 (22.1, 4.8) 0.45
6m 20.6 (1.6) 20.5 (1.6) 0.1 (24.3, 4.5) 0.96 20.2 (23.9, 3.4) 0.89
12m 21.8 (1.6) 21.2 (1.6) 0.6 (23.8, 5.0) 0.80 0.3 (23.4, 4.1) 0.85
18m 21.0 (1.6) 20.8 (1.6) 0.2 (24.2, 4.6) 0.93 1.4 (22.4, 5.2) 0.48
Triglycerides (mg/dl)
3m 210.8 (7.4) 212.5 (7.1) 21.7 (221.9, 18.5) 0.87 22.7 (220.6, 15.2) 0.76
6m 220.4 (7.5) 219.4 (7.4) 1.0 (219.4, 21.4) 0.92 215.3 (233.9, 3.3) 0.11
12m 219.3 (7.7) 29.3 (7.6) 10.0 (210.9, 30.9) 0.34 222.7 (242.2, 23.1) 0.02
18m 214.0 (7.6) 211.5 (7.6) 2.5 (218.2, 23.1) 0.81 210.9 (230.3, 8.5) 0.27
Triglyceride/HDL ratio
3m 20.22 (0.18) 20.25 (0.18) 20.02 (20.54, 0.49) 0.93 20.17 (20.61, 0.28) 0.46
6m 20.52 (0.19) 20.40 (0.18) 0.12 (20.40, 0.64) 0.65 20.39 (20.85, 0.06) 0.09
12m 20.40 (0.19) 20.17 (0.19) 0.23 (20.29, 0.76) 0.38 20.68 (21.16, 20.21) 0.01
18m 20.33 (0.19) 20.21 (0.19) 0.12 (20.40, 0.64) 0.64 20.42 (20.89, 0.05) 0.08
C-reactive protein (mg/l)
3m 20.9 (0.8) 21.4 (0.7) 20.5 (22.6, 1.5) 0.61 20.6 (22.3, 1.0) 0.45
6m 21.2 (0.7) 21.4 (0.7) 20.2 (22.3, 1.8) 0.82 20.4 (22.1, 1.3) 0.64
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The 18-month time point, therefore, reflects 1-year maintenance
effects after withdrawal of intervention support. We designed a rigor-
ous control by controlling for attention, social support, expectations of
benefit, diet-exercise guidelines, and elements of a mindfulness
approach to stress management by providing limited progressive mus-
cle relaxation and cognitive–behavioral training in the control condi-
tion. The dietary intervention used in both interventions was also mod-
est in that we promoted sustainable, long-term caloric reduction with
minimal use of food records (35). Interventions that integrate mindful-
ness training with more intensive dietary or exercise guidelines or
other effective cognitive–behavioral therapies compatible with a mind-
fulness approach may achieve greater improvements. The cost of add-
ing mindfulness components was modest, about $200 per participant.
In behavioral intervention trials, it is essentially impossible to mask
participants to the intervention they receive. We made an effort,
however, to mask participants to the fact that we were specifically
testing effects of a mindfulness-enhanced intervention to prevent
decreased expectations and drop out among participants assigned to
the control arm. We assumed the majority of participants would
have preferred to receive the mindfulness-enhanced intervention.
The concealment of intervention content prior to randomization,
however, may have led to the assignment of some participants to the
mindfulness arm who had little interest in mindfulness. This
approach may have resulted in treatment effects that are more con-
servative than those in trials or clinical settings in which potential
participants choose to enroll in a mindfulness-based program. To
assess this explanation, we compared participants missing 18-month
data in the mindfulness arm (n 5 19) to the active control (n 5 27).
Drop-outs in the mindfulness arm reported greater reductions in
expectations of benefit after randomization (but prior to the first ses-
sion), attended fewer classes, and showed trends of less improve-
ment in metabolic outcomes. These findings support the notion that
many drop-outs in the mindfulness arm may have had limited inter-
est in the mindfulness components of the intervention. It may also
explain why analyses using only observed data tended to show
stronger effects of the mindfulness intervention on outcomes, includ-
ing HOMA, HDL, and C-reactive protein, than the imputation analy-
ses. These findings suggest that participant engagement is important
and individuals with obesity who do not express interest in mindful-
ness approaches may respond less favorably to the inclusion of
mindfulness training in weight loss programs.
Our results also suggest that efficacy of mindfulness training for
weight loss may be instructor-dependent. Groups led by mindfulness
instructors who were rated by participants as more helpful during
the intervention lost an estimated 4.3 kg more at 18 months com-
pared to groups led by an instructor rated as less helpful and 5.4 kg
more than contemporaneous control groups, both statistically signifi-






















12m 20.8 (0.8) 20.3 (0.8) 0.5 (21.7, 2.7) 0.64 20.7 (22.6, 1.2) 0.46
18m 21.0 (0.8) 20.8 (0.8) 0.1 (22.0, 2.3) 0.92 21.3 (23.2, 0.5) 0.15
Systolic blood pressure (mm Hg)
3m 210.0 (3.0) 26.5 (3.0) 3.5 (24.9, 11.9) 0.41 23.4 (29.3, 2.4) 0.24
6m 27.7 (3.0) 23.7 (3.0) 3.9 (24.4, 12.3) 0.35 23.0 (29.0, 2.9) 0.32
12m 23.5 (3.1) 22.2 (3.1) 1.3 (27.1, 9.7) 0.76 21.9 (28.0, 4.2) 0.54
18m 23.7 (3.0) 1.0 (3.0) 4.7 (23.7, 13.1) 0.27 22.5 (28.5, 3.6) 0.42
Diastolic blood pressure (mm Hg)
3m 21.4 (1.6) 21.9 (1.5) 20.5 (24.7, 3.8) 0.83 20.2 (23.8, 3.4) 0.92
6m 22.3 (1.6) 21.3 (1.6) 1.0 (23.3, 5.2) 0.65 21.1 (24.7, 2.6) 0.57
12m 1.9 (1.6) 20.2 (1.6) 22.1 (26.4, 2.2) 0.34 0.4 (23.4, 4.2) 0.83
18m 0.9 (1.6) 2.8 (1.6) 1.9 (22.5, 6.2) 0.39 20.6 (24.5, 3.3) 0.77
Note: Participants who had mindfulness instructors who were rated as more helpful (A/B) were compared to participants who had the mindfulness instructor who was
rated as less helpful (C) in mixed models using multiple imputation to replace missing data. Imputation models for each outcome variable included values at other time
points and attendance (counting the all-day session as two).
Figure 3 Changes in weight by mindfulness instructor groups. Changes from trial
initiation in weight in the mindfulness arm by groups led by instructors A and B
(black line) and groups led by instructor C (gray line). Instructors A and B were
rated higher on helpfulness by participants compared to Instructor C. Standard
error bars are shown. See Table 3 for statistical tests at different time points.
m 5 months.
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instructors may produce more weight loss benefit in mindfulness-
enhanced interventions. We monitored adherence to a detailed inter-
vention manual, yet instructor differences persisted in how the cur-
riculum was delivered. Based on supervisor observations, closer
adherence to the manual, at the possible cost of fuller personal
engagement with group participants, could be a factor explaining
instructor differences (36), consistent with findings in the psycho-
therapy literature (37). However, as we did not randomize instruc-
tors, findings could be due to chance, other explanations may be
valid, and therefore, interpretation of these results requires caution.
Further research is needed to investigate effects of instructor charac-
teristics on outcomes of mindfulness-based interventions.
In conclusion, the effect of adding mindfulness components to diet-
exercise programs on weight loss in individuals with obesity was
not statistically significant. We found some evidence that the mind-
fulness intervention may lead to long-term maintenance of fasting
glucose levels and improved atherogenic lipid profiles. Further
research is needed to determine whether potential benefits can be
confirmed or strengthened.O
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